Albuminuria and renal function in homozygous sickle cell disease: Observations from a cohort study

Archives of Internal Medicine

Volumn 167, Issue 7, 2007, Pages 701-708

  Thompson, Joanne ^a   Reid, Marvin ^a   Hambleton, Ian ^a,b   Serjeant, Graham R ^a,c  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY OF THE WEST INDIES   (Jamaica)

^c Ministry of Health   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; CIMETIDINE; CREATININE; EDETIC ACID;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DRUG CLEARANCE; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ALBUMINURIA; ANEMIA, SICKLE CELL; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HOMOZYGOTE; HUMANS; KIDNEY; MALE; PROSPECTIVE STUDIES; RENAL CIRCULATION;

EID: 34247173365     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.7.701     Document Type: Article

References (32)

1. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle-cell disease in Jamaica. BMJ. 1982;285:633-635.
2. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1644.
3. Wierenga KJ, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet. 2001;357:680-683.
4. Etteldorf JN, Tuttle AW, Clayton GW. Renal function studies in pediatrics, I: renal hemodynamics in children with sickle cell anemia. AJDC. 1952;83:185-191.
5. Etteldorf JN, Smith JD, Tuttle AH, Diggs LW. Renal hemodynamic studies in adults with sickle cell anemia. Am J Med. 1955;18:243-248.
6. Hatch FE Jr, Azar SH, Ainsworth TE, Nardo JM, Culbertson JW. Renal circulatory studies in young adults with sickle cell anemia. J Lab Clin Med. 1970;76:632-640.
7. Mogensen CE, Hansen KW, Nielsen S, Pedersen MM, Rehling M, Schmitz A. Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease: reproducibility, progression, and efficacy of antihypertensive intervention. Am J Kidney Dis. 1993;22:174-187.
8. Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med. 1992;326:910-915.
9. Aoki RY, Saad ST. Enalapril reduces the albuminuria of patients with sickle cell disease. Am J Med. 1995;98:432-435.
10. Serjeant GR, Serjeant BE, Forbes M, Hayes RJ, Higgs DR, Lehmann H. Haemoglobin gene frequencies in the Jamaican population: a study in 100,000 newborns. Br J Haematol. 1986;64:253-262.
11. Serjeant BE, Forbes M, Williams LL, Serjeant GR. Screening cord bloods for detection of sickle cell disease in Jamaica. Clin Chem. 1974;20:666-669.
12. Serjeant GR, Serjeant BE. Sickle Cell Disease. 3rd ed. Oxford, England: Oxford University Press; 2001.
13. Silver A, Dawnay A, Landon J, Cattell WR. Immunoassays for low concentrations of albumin in urine. Clin Chem. 1986;32:1303-1306.
14. Wagoner RD, Tauxe WN, Maher FT, Hunt JC. Measurement of effective renal plasma flow with sodium iodohippurate I-131. JAMA. 1964;187:811-813.
15. Chantler C, Barratt TM. Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child. 1972;47:613-617.
16. Royston P. A toolkit for testing nonnormality in complete and censored samples. Statistician. 1993;42:37-43. doi:10.2307/2348109.
17. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Ser B. 1964;26:211-252.
18. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135-160.
19. Powars DR, Elliott-Mills DD, Chan L, et al. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med. 1991;115:614-620.
20. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830-838.
21. Rahn KH, Heidenreich S, Bruckner D. How to assess glomerular function and damage in humans. J Hypertens. 1999;17:309-317.
22. Singhal A, Parker S, Linsell L, Serjeant G. Energy intake and resting metabolic rate in preschool Jamaican children with homozygous sickle cell disease. Am J Clin Nutr. 2002;75:1093-1097.
23. Reid M, Badaloo A, Forrester T, Jahoor F. In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease. Am J Physiol Endocrinol Metab. 2006;291:E73-E79.
24. Rehling M, Moller ML, Thamdrup B, Lund JO, Trap-Jensen J. Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci (Lond). 1984;66:613-619.
25. Hilbrands LB, Artz MA, Wetzels JF, Koene RA. Cimetidine improves the reliability of creatinine as a marker of glomerular filtration. Kidney Int. 1991;40:1171-1176.
26. van Acker BA, Koomen GC, Koopman MG, de Waart DR, Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet. 1992;340:1326-1329.
27. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985;76:612-619.
28. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ. 1992;304:339-343.
29. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med. 1993;118:577-581.
30. Apperloo AJ, de Zeeuw D, Sluiter HE, de Jong PE. Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease. BMJ. 1991;303:821-824.
31. Hommel E, Mathiesen ER, Giese J, Nielsen MD, Schutten HJ, Parving HH. On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy. Scand J Clin Lab Invest. 1989;49:537-544.
32. Imanishi M, Yoshioka K, Okumura M, et al. Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients. Diabetes Care. 2001;24:111-116.